Human papillomavirus prevalence and cytopathology correlation in young Ugandan women using a low-cost liquid-based Pap preparation

Diagnostic Cytopathology
Janis M TaubeJ Brooks Jackson

Abstract

Screening for HPV-driven cervical dysplasia and neoplasia is a significant public health concern in the developing world. The purpose of this study was to use a manual, low-cost liquid-based Pap preparation to determine HPV prevalence in HIV-positive and HIV-negative young women in Kampala, Uganda and to correlate cervical cytopathology with HPV-DNA genotype. About 196 post-partum women aged 18-30 years underwent rapid HIV testing and pelvic examination. Liquid-based cervical cytology samples were processed using a low-cost manual technique. A DNA collection device was used to collect specimens for HPV genotyping. HIV and HPV prevalence was 18 and 64%, respectively. Overall, 49% of women were infected with a high-risk HPV genotype. The most common high-risk HPV genotypes were 16 (8.2%), 33 (7.7%), 35 (6.6%), 45 (5.1%), and 58 (5.1%). The prevalence of HPV 18 was 3.6%. HIV-positive women had an HPV prevalence of 86% compared to 59% in HIV-negative women (P = 0.003). The prevalence of HPV 16/18 did not differ by HIV status. HIV-positive women were infected with a significantly greater number of HPV genotypes compared to HIV-negative women. By multivariate analysis, the main risk factor for HPV infection was coinfection with HIV. ...Continue Reading

References

Jun 19, 1992·International Journal of Cancer. Journal International Du Cancer·J ter MeulenX Yu
Nov 14, 1997·The New England Journal of Medicine·X W SunT C Wright
Aug 19, 1999·The Journal of Pathology·J M WalboomersN Muñoz
Nov 26, 1999·The New England Journal of Medicine·K L WallinJ Dillner
Jan 5, 2000·Journal of Clinical Microbiology·P E GravittR J Apple
Jan 12, 2000·AIDS·D M ParkinF Wabwire-Mangen
Mar 4, 2000·JAMA : the Journal of the American Medical Association·T V EllerbrockT C Wright
Jun 17, 2000·Journal of Virological Methods·M E Fernández-ContrerasP A Lazo
Apr 23, 2002·JAMA : the Journal of the American Medical Association·Diane SolomonUNKNOWN Bethesda 2001 Workshop
Jun 17, 2003·Journal of the National Cancer Institute. Monographs·F Xavier Bosch, Silvia de Sanjosé
Jun 16, 2004·International Journal of Cancer. Journal International Du Cancer·Nubia MuñozChris J L M Meijer
Sep 8, 2004·International Journal of Cancer. Journal International Du Cancer·Rengaswamy SankaranarayananBernard Fontaniere
May 17, 2005·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Gary M CliffordJeanne M Pimenta
Sep 10, 2005·International Journal of Cancer. Journal International Du Cancer·Sylvia TaylorThomas C Wright
Nov 3, 2005·JAMA : the Journal of the American Medical Association·Lynette DennyThomas C Wright
Nov 3, 2005·JAMA : the Journal of the American Medical Association·Wendy R BrewsterAlberto Manetta
Nov 18, 2005·The New England Journal of Medicine·Mark Schiffman, Philip E Castle
Nov 18, 2005·The New England Journal of Medicine·Sue J GoldieUNKNOWN Alliance for Cervical Cancer Prevention Cost Working Group
Mar 2, 2006·Journal of the National Cancer Institute·Xavier CastellsaguéUNKNOWN International Agency for Research on Cancer Multicenter Cervical Cancer Study Group
Apr 22, 2006·American Journal of Obstetrics and Gynecology·Judy M LeeDouglas P Clark
May 5, 2006·Advances in Dental Research·J Palefsky
Feb 17, 2007·Diagnostic Cytopathology·Eric J SubaUNKNOWN Viet/American Cervical Cancer Prevention Project
Apr 4, 2007·International Journal of Cancer. Journal International Du Cancer·Jennifer S SmithGary M Clifford
May 15, 2007·The New England Journal of Medicine·UNKNOWN FUTURE II Study Group
May 15, 2007·The New England Journal of Medicine·Suzanne M GarlandUNKNOWN Females United to Unilaterally Reduce Endo/Ectocervical Disease (FUTURE) I Investigators
May 15, 2007·The New England Journal of Medicine·George F Sawaya, Karen Smith-McCune
Aug 19, 2007·The Journal of Infectious Diseases·Ali Rowhani-RahbarNancy B Kiviat
Sep 4, 2007·International Journal of Cancer. Journal International Du Cancer·Hugo De VuystMarleen Temmerman
Jan 1, 2008·Obstetrics and Gynecology·George F Sawaya
Jan 1, 2008·Obstetrics and Gynecology·Marc ArbynJohan Bulten
Feb 2, 2008·The Journal of Infectious Diseases·Cecily BanuraElisabete Weiderpass
Jun 26, 2008·BMC Infectious Diseases·Michael OdidaElisabete Weiderpass
Aug 22, 2008·The New England Journal of Medicine·Charlotte J Haug
Oct 14, 2008·Vaccine·Patti E GravittCosette M Wheeler
Oct 23, 2008·Journal of the American College of Cardiology·Anthony N DeMaria

❮ Previous
Next ❯

Citations


❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.